论文部分内容阅读
治疗心律失常新药索他洛尔盐酸索他洛尔（ＳｏｔａｌｏｌＨＣｌ，Ｂｅｔａｐａｃｅ－Ｂｅｒｌｅｘ药厂）是一种治疗威胁生命的室性心律失常的新药。据估计每年大约１５００００病人受此病影响。该药已获美国ＦＤＡ优先审查资格，兼有β－受体阻断剂和抗心律失常的功能。心...
New Drug for the Treatment of Arrhythmias Sotalol HCl (Betapace-Berlex) is a new drug for the treatment of life-threatening ventricular arrhythmias. It is estimated that about 150,000 patients are affected by the disease each year. The drug has been the US FDA priority review, both β-blockers and anti-arrhythmic function. heart...